Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126968181 | 12696818 | 1 | I | 20160608 | 20160830 | 20160830 | PER | JP-LUPIN PHARMACEUTICALS INC.-2016-02722 | LUPIN | SOMA N. NOTES OF MEDICAL COOPERATION STUDIED FROM INTERACTION CASE OF WARFARIN POTASSIUM AND AZITHROMYCIN SINGLE DOSE PREPARATION. DRUG INTERACTION STUDIES. 2016;39 (3):41-45. | 59.00 | YR | M | Y | 0.00000 | 20160830 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126968181 | 12696818 | 1 | PS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | SINGLE DOSE | UNKNOWN | 65398 | 2 | G | |||||||
| 126968181 | 12696818 | 2 | I | Warfarin potassium | WARFARIN POTASSIUM | 1 | Unknown | 2.5 MG | UNKNOWN | 0 | |||||||||
| 126968181 | 12696818 | 3 | I | Warfarin potassium | WARFARIN POTASSIUM | 1 | Unknown | 1 MG | UNKNOWN | 0 | |||||||||
| 126968181 | 12696818 | 4 | I | Warfarin potassium | WARFARIN POTASSIUM | 1 | Unknown | 2 MG | UNKNOWN | 0 | |||||||||
| 126968181 | 12696818 | 5 | C | TAMSULOSIN HYDROCHLORIDE. | TAMSULOSIN HYDROCHLORIDE | 1 | Unknown | 0 | .2 | MG | |||||||||
| 126968181 | 12696818 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 0 | 20 | MG | |||||||||
| 126968181 | 12696818 | 7 | C | Iron sulfate | FERROUS SULFATE ANHYDROUS | 1 | Unknown | 0 | 210 | MG | |||||||||
| 126968181 | 12696818 | 8 | C | FLUVOXAMINE MALEATE. | FLUVOXAMINE MALEATE | 1 | Unknown | 0 | 50 | MG | |||||||||
| 126968181 | 12696818 | 9 | C | OLOPATADINE HYDROCHLORIDE. | OLOPATADINE HYDROCHLORIDE | 1 | Unknown | 0 | 10 | MG | |||||||||
| 126968181 | 12696818 | 10 | C | Etizolam | ETIZOLAM | 1 | Unknown | 0 | 1.5 | MG | |||||||||
| 126968181 | 12696818 | 11 | C | Mosapride salt | 2 | Unknown | 0 | 15 | MG | ||||||||||
| 126968181 | 12696818 | 12 | C | Morphine hydrochloride | MORPHINE HYDROCHLORIDE | 1 | Unknown | 0 | 10 | MG | |||||||||
| 126968181 | 12696818 | 13 | C | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Unknown | 0 | 20 | MG | |||||||||
| 126968181 | 12696818 | 14 | C | Flunitrazepam | FLUNITRAZEPAM | 1 | Unknown | 0 | 1 | MG | |||||||||
| 126968181 | 12696818 | 15 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Unknown | 0 | 990 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126968181 | 12696818 | 1 | Upper respiratory tract infection |
| 126968181 | 12696818 | 2 | Cerebral artery embolism |
| 126968181 | 12696818 | 3 | Atrial fibrillation |
| 126968181 | 12696818 | 5 | Product used for unknown indication |
| 126968181 | 12696818 | 6 | Product used for unknown indication |
| 126968181 | 12696818 | 7 | Product used for unknown indication |
| 126968181 | 12696818 | 8 | Product used for unknown indication |
| 126968181 | 12696818 | 9 | Product used for unknown indication |
| 126968181 | 12696818 | 10 | Product used for unknown indication |
| 126968181 | 12696818 | 11 | Product used for unknown indication |
| 126968181 | 12696818 | 12 | Product used for unknown indication |
| 126968181 | 12696818 | 13 | Product used for unknown indication |
| 126968181 | 12696818 | 14 | Product used for unknown indication |
| 126968181 | 12696818 | 15 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126968181 | 12696818 | Drug interaction | |
| 126968181 | 12696818 | International normalised ratio increased | |
| 126968181 | 12696818 | Prothrombin time prolonged |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |